2020-09-27@08:11:38 GMT
29 results - (0.000 seconds)

News about pharmaceuticals:

    [The stream is slated to start at 11:30 a.m. ET. Please refresh the page if you do not see a player above at that time.] The World Health Organization is holding a press briefing Friday on the coronavirus pandemic, which has infected more than 32 million people worldwide, according to data compiled by Johns Hopkins University. The...
    The whole world is watching — including investors and public health specialists — as more than 30 biotech and pharmaceutical companies race to develop a safe Covid-19 vaccine. But there's a big question lingering over the process: How do we balance safety with speed? The process is moving quickly with several vaccine candidates entering late stage...
    A potential acquisition of supplement chain GNC by Chinese-owned Harbin Pharmaceuticals has sparked concern in Congress and among allies of President Trump's "America First" trade policy, who are calling for a national security review of the deal over claims it could grant Beijing-controlled Harbin access to U.S. military bases and service members' sensitive information. Florida...
    ADHD in teenagers may be triggered by exposure to a group of common chemicals used in applications from food packaging and drugs to cosmetics and fragrances. US experts found associations between attention-deficit/hyperactivity disorder-related behaviour and endocrine-disrupting chemicals, especially phthalates. Phthalates are typically added to plastics to improve their flexibility, transparency, durability and longevity.  According to...
    NEW YORK (AP) — Stocks that moved heavily or traded substantially Wednesday: Momenta Pharmaceuticals Inc., up $21.31 to $52.12. Johnson & Johnson is buying the biotechnology company for $6.5 billion. Hudson Ltd., up $2.33 to $7.46. Dufry Group AG, the travel retailer’s majority owner, is buying the remaining shares of the company. BioMarin Pharmaceutical...
    Working mothers are quitting to take care of their kids, and the US job market may never be the same Fast food brands we wish would make a comeback Johnson & Johnson to Acquire Momenta Pharmaceuticals for $6.5 Billion in Cash Johnson & Johnson (NYSE: JNJ) just took a big step into the field...
    Coronavirus updates: North Carolina State University reports first cluster of cases; Hawaii delays tourism reopening; global cases top 22M CDC: Salmonella outbreak linked to onions expands Johnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 Billion Johnson & Johnson said Wednesday that it will buy Momenta Pharmaceuticals for roughly $6.5 billion in...
    Lionel Messi is key to his new boss plans, and is going nowhere despite rumors of a $700 million Barcelona exit How mortality rates in every state have changed during COVID-19 Regeneron Partners With Roche to Make Covid-19 Drug Regeneron Pharmaceuticals has teamed with rival Roche to help make and distribute REGN-COV2,...
    Jakub Porzycki | NurPhoto | Getty Images Johnson & Johnson said on Wednesday it would buy Momenta Pharmaceuticals for about $6.5 billion in cash to expand into the area of autoimmune disease treatments. J&J will pay $52.50 for each Momenta share, a 70.4% premium to Tuesday's closing price.Related Tags Health care industry Business Biotech and...
    A technician at Regeneron Pharmaceuticals headquarters in Tarrytown, New York.Mike Segar | Reuters Regeneron and Roche are teaming up on an investigational antibody cocktail against Covid-19, with the U.S. company to sell it in the United States and the Swiss drugmaker to sell it elsewhere, should the drug win approval. Regeneron has said it expects...
    [The stream is slated to start at 11:00 a.m. ET. Please refresh the page if you do not see a player above at that time.] World Health Organization officials are holding a press conference on Thursday to update the public on the coronavirus outbreak that has infected more than 20 million people across the globe. ...
    An agreement between the US government and Kodak to develop generic drug ingredients appears to be on hold, after the US International Development Finance Corporation tweeted that “recent allegations of wrongdoing raise serious concerns.” “We will not proceed any further unless these allegations are cleared,” the agency tweeted, without specifying what the allegations were....
    Kodak, once a powerful force in photography, is branching out into pharmaceuticals and the US government plans to give the company a $765 million loan to support its efforts. Kodak will create a new business arm, Kodak Pharmaceuticals, to produce ingredients needed for drug manufacturing. Kodak Pharmaceuticals will make ingredients that have “lapsed into chronic...
    The Eastman Kodak Company has secured a $765 million Defense Production Act loan to help the United States repatriate essential pharmaceuticals manufacturing. With the help of the loan, Kodak will create likely 350 American jobs in the Rochester, New York, region and produce ingredients for drugs such as hydroxychloroquine and other essential pharmaceuticals that currently...
    The phrase “Kodak moment” could soon have a new meaning. Kodak, a 132-year-old camera company, is launching a new pharmaceuticals arm with help from Uncle Sam, officials announced Tuesday. The Trump administration awarded the onetime photography titan $765 million under the Defense Production Act to make ingredients for a wide range of drugs in an...
    Eastman Kodak Co. has received a $765 million government loan to help expedite the domestic production of drugs to treat a variety of medical conditions and loosen the country's reliance on foreign sources, the U.S. International Development Finance Corporation (DFC) announced Tuesday.  The loan, which is the first of its kind under the Defense Production...
    U.S. President Donald Trump is seated prior to signing an executive order regarding social media companies in the Oval Office of the White House in Washington, U.S., May 28, 2020.Jonathan Ernst | Reuters President Donald Trump announced Friday he will sign four executive orders aimed at lowering the high cost of prescription drugs in the United...
    WASHINGTON (Reuters) - Taro Pharmaceutical agreed to pay more than $200 million to settle allegations that it conspired to fix the prices of generic drugs, the Justice Department said on Thursday. The company is the fifth pharmaceutical company to admit that it fixed the prices of generic medicines. Under the terms of a three-year deferred...
    VIDEO2:5002:50ETF Edge: Health care and tech stocks close at recordsETF Edge Health-care stocks are hot. The group hit record highs on Monday after a potential coronavirus vaccine developed by Oxford University and AstraZeneca showed promising responses in an early trial, creating a lift in the relatively broad health-care space. In addition to the Health Care...
    A doctor who has been studying lung disease for 15 years has warned of a looming health crisis that could overshadow the impact of COVID-19 in the long term. Dr. Sassan Rafi, who has carried out extensive research into crippling pulmonary fibrosis, one of the conditions now linked to acute coronavirus patients, claims thousands of...
    A technician at Regeneron Pharmaceuticals headquarters in Tarrytown, New York.Mike Segar | Reuters Regeneron Pharmaceuticals said on Tuesday the U.S. government has granted the drugmaker a $450 million contract to make and supply its double-antibody cocktail that is being tested against Covid-19. The antiviral cocktail, REGN-COV2, is in separate clinical trials both for treating and...
    A technician at Regeneron Pharmaceuticals headquarters in Tarrytown, New York.Mike Segar | Reuters Regeneron Pharmaceuticals said on Monday it began late-stage clinical trials to assess the effectiveness of its antibody cocktail in preventing and treating Covid-19. The trial, run jointly with the National Institute of Allergy and Infectious Diseases, would test the therapy's ability to prevent...
    Also Inquires About Boosting Domestic Production of Pharmaceuticals, Medical Supplies At a U.S. Senate Health, Education, Labor and Pensions Committee hearing, U.S. Senator Kelly Loeffler (R-Ga.) asked administration officials about how they plan to handle COVID-19 this fall and what steps the administration could take to increase domestic production of pharmaceuticals and medical supplies. Loeffler...
    MONTGOMERY COUNTY, Pa. (CBS) — On Tuesday, Plymouth Meeting-based company Inovio Pharmaceuticals announced positive results from early-stage testing of its COVID-19 vaccine. But officials with the biotechnology company did not disclose complete data. This sent shares of the company’s stock tumbling on Wall Street. Download The New And Improved CBS Philly App! Inovio’s CEO explains...
    Inovio Pharmaceuticals said Tuesday that it received $ 71 million from the United States Department of Defense to expand the manufacturing of its own device to inject its candidate for the covid-19 vaccine into the skin. The company began phase 1 of human clinical trials in April for its DNA-based vaccine, with results expected later...
    NEW YORK (AP) - Stocks that moved heavily or traded substantially on Thursday: Moderna Inc., up 13 cents to $60.20 The biotechnology company’s potential COVID-19 vaccine is on track to begin a huge study in July. TOP STORIES California sheriffs deputy shot in ambush attack; gunman at large Mass. college deeply sorry for letting police...